Results 141 to 150 of about 113,966 (168)

En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH

Cell, 2022
Kentaro Iwasawa, Yosuke Yoneyama, Gaohui Zhu   +2 more
exaly  

MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH

Cell Metabolism, 2022
Gautam Bandyopadhyay, Wei Ying, Jerrold M Olefsky   +2 more
exaly  

Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia

Cell Metabolism, 2022
Jianhan Wu, Pedrum Mohammadi-Shemirani, Zhichao Wang   +2 more
exaly  

Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment

Cell Metabolism, 2022
Xuelian Xiong
exaly  

NASH v. NASH

Victorian Reports, 1919
openaire   +1 more source

A GLP‐1/GLP‐2 receptor dual agonist to treat NASH: Targeting the gut‐liver axis and microbiome

Hepatology, 2022
Jeong Su Park, Ji Young Oh, Yu Seol Lee
exaly  

Vitamin B12 and folate decrease inflammation and fibrosis in NASH by preventing syntaxin 17 homocysteinylation

Journal of Hepatology, 2022
Madhulika Tripathi, Brijesh K Singh, Jin Zhou   +2 more
exaly  

Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model

Biomaterials, 2020
Mohamed Elbadawy, Ryouichi Tsunedomi, Toshinori Yoshida   +2 more
exaly  

The Role of Cholesterol in the Pathogenesis of NASH

Trends in Endocrinology and Metabolism, 2016
George N Ioannou
exaly  

Obesity, insulin resistance, NASH and hepatocellular carcinoma

Seminars in Cancer Biology, 2013
Jun Yu, Jiayun Shen, Xiang Zhang
exaly